Article Details
Retrieved on: 2020-11-23 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
23, 2020 (GLOBE NEWSWIRE) -- Mereo <b>BioPharma</b> Group plc (NASDAQ: MREO, AIM: MPH) (“Mereo” or “the Company”), a clinical stage ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here